Source: Annual Congress 2010 - Biomarkers for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ryuge, Y. Sato, G. Wang, M. Yokoba, M. Katagiri, N. Masuda (Sagamihara, Japan). Prognostic significance of Nestin in resected non-small cell lung cancer. Eur Respir J 2010; 36: Suppl. 54, 3234

Member's Comments

No comment yet.

Related content which might interest you: Prognostic significance of S-100 immmunostaining in non-small cell lung cancer (NSCLC) Source: Annual Congress 2004 - Prognostic factors Year: 2004 Prognostic factors in non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006 Prognostic factors for unresectable non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer Source: Eur Respir J 2001; 17: 660-666 Year: 2001 Prognostic value of Her2/neu in stage IIIA non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Clinico-morphological prognostic factors of resected non-small cell lung carcinoma Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008 Prognostic value of p21 protein expression in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Ki-67 in non-small cell lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008 Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002 Diagnostic significance of ADAM8 and M2-PK in non-small cell lung cancer Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Prognostic value of apoptotic index in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004 Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007 Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Prognostic  value of  EGFR  genotype  in  EGFR-mutant  non-small  cell lung  cancer Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Survival and clinico-pathologic prognostic factors in surgically resected non-small cell lung carcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006 Prognostic significance of MUC1 expression in resected lung adenocarcinoma Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008